Literature DB >> 25891017

Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS.

Woong-Ki Kim1, Christopher M McGary1, Gerard E Holder1, Adam R Filipowicz1, Michael M Kim1, Hind A Beydoun2, Yanhui Cai3, Xianhong Liu4, Chie Sugimoto3, Marcelo J Kuroda3.   

Abstract

Increased expression of CD169 on monocytes has been reported in HIV-1-infected humans. Using rhesus macaque models of HIV infection, we sought to investigate whether simian immunodeficiency virus (SIV) infection upregulates CD169 expression on monocytes/macrophages. We also sought to determine whether CD8 T cells and plasma viral load directly impact the expression of CD169 on monocytes during SIV infection. We longitudinally assessed monocyte expression of CD169 during the course of SIV infection by flow cytometry, and examined the expression of CD169 on macrophages by immunohistochemistry in the spleen and lymph nodes of uninfected and infected macaques. CD169 expression on monocytes was substantially upregulated as early as 4 days during the hyperacute phase and peaked by 5-15 days after infection. After a transient decrease following the peak, its expression continued to increase during progression to AIDS. Monocyte CD169 expression was directly associated with plasma viral loads. To determine the contribution of CD8(+) T lymphocytes and virus to the control of monocyte CD169 expression, we used experimental CD8(+) lymphocyte depletion and antiretroviral therapy (ART) in SIV-infected macaques. Rapid depletion of CD8 T cells during acute infection of rhesus macaques induced an abrupt increase in CD169 expression. Importantly, levels of CD169 expression plummeted following initiation of ART and rebounded upon cessation of therapy. Taken together, our data reveal independent roles for virus and CD8(+) T lymphocytes in controlling monocyte CD169 expression, which may be an important link in further investigating the host response to viral infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25891017      PMCID: PMC4505761          DOI: 10.1089/AID.2015.0003

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  32 in total

1.  Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.

Authors:  B Odermatt; M Eppler; T P Leist; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

Review 2.  The potential role of sialoadhesin as a macrophage recognition molecule in health and disease.

Authors:  P R Crocker; A Hartnell; J Munday; D Nath
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

Authors:  Kenichi Asano; Ami Nabeyama; Yasunobu Miyake; Chun-Hong Qiu; Ai Kurita; Michio Tomura; Osami Kanagawa; Shin-ichiro Fujii; Masato Tanaka
Journal:  Immunity       Date:  2010-12-30       Impact factor: 31.745

4.  Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection.

Authors:  Mireille Centlivre; Nicolas Legrand; Radjin Steingrover; Renee van der Sluis; Marlous L Grijsen; Margreet Bakker; Suzanne Jurriaans; Ben Berkhout; William A Paxton; Jan M Prins; Georgios Pollakis
Journal:  J Leukoc Biol       Date:  2011-02-10       Impact factor: 4.962

5.  Increased Siglec-1 expression in monocytes of patients with primary biliary cirrhosis.

Authors:  Guangyu Bao; Zhijun Han; Zihe Yan; Qihong Wang; Ye Zhou; Dingkang Yao; Mingli Gu; Bo Chen; Sunxiao Chen; Anmei Deng; Renqian Zhong
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 6.  Macrophages: do they impact AIDS progression more than CD4 T cells?

Authors:  Marcelo J Kuroda
Journal:  J Leukoc Biol       Date:  2010-01-06       Impact factor: 4.962

7.  Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus.

Authors:  Matteo Iannacone; E Ashley Moseman; Elena Tonti; Lidia Bosurgi; Tobias Junt; Sarah E Henrickson; Sean P Whelan; Luca G Guidotti; Ulrich H von Andrian
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

Review 8.  Monocyte/macrophage traffic in HIV and SIV encephalitis.

Authors:  Woong-Ki Kim; Sarah Corey; Xavier Alvarez; Kenneth Williams
Journal:  J Leukoc Biol       Date:  2003-08-11       Impact factor: 4.962

9.  HIV/SIV infection primes monocytes and dendritic cells for apoptosis.

Authors:  Mireille Laforge; Laure Campillo-Gimenez; Valérie Monceaux; Marie-Christine Cumont; Bruno Hurtrel; Jacques Corbeil; John Zaunders; Carole Elbim; Jérôme Estaquier
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

10.  Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids.

Authors:  Zhongcheng Zou; Ashley Chastain; Susan Moir; Jennifer Ford; Kathryn Trandem; Elena Martinelli; Claudia Cicala; Paul Crocker; James Arthos; Peter D Sun
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

View more
  14 in total

1.  Comprehensive Immunoprofiling of Pediatric Zika Reveals Key Role for Monocytes in the Acute Phase and No Effect of Prior Dengue Virus Infection.

Authors:  Daniela Michlmayr; Eun-Young Kim; Adeeb H Rahman; Rohit Raghunathan; Seunghee Kim-Schulze; Yan Che; Selim Kalayci; Zeynep H Gümüş; Guillermina Kuan; Angel Balmaseda; Andrew Kasarskis; Steven M Wolinsky; Mayte Suaréz-Fariñas; Eva Harris
Journal:  Cell Rep       Date:  2020-04-28       Impact factor: 9.423

2.  A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.

Authors:  Scott G Hansen; Emily E Marshall; Daniel Malouli; Abigail B Ventura; Colette M Hughes; Emily Ainslie; Julia C Ford; David Morrow; Roxanne M Gilbride; Jin Y Bae; Alfred W Legasse; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Jennie Womack; Jason Shao; Paul T Edlefsen; Jason S Reed; Ben J Burwitz; Jonah B Sacha; Michael K Axthelm; Klaus Früh; Jeffrey D Lifson; Louis J Picker
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

3.  Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Authors:  Suzanne D G Kijewski; Hisashi Akiyama; Amin Feizpour; Caitlin M Miller; Nora-Guadalupe P Ramirez; Björn M Reinhard; Suryaram Gummuluru
Journal:  Virology       Date:  2016-08-11       Impact factor: 3.616

4.  Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.

Authors:  Afam A Okoye; Scott G Hansen; Mukta Vaidya; Yoshinori Fukazawa; Haesun Park; Derick M Duell; Richard Lum; Colette M Hughes; Abigail B Ventura; Emily Ainslie; Julia C Ford; David Morrow; Roxanne M Gilbride; Alfred W Legasse; Joseph Hesselgesser; Romas Geleziunas; Yuan Li; Kelli Oswald; Rebecca Shoemaker; Randy Fast; William J Bosche; Bhavesh R Borate; Paul T Edlefsen; Michael K Axthelm; Louis J Picker; Jeffrey D Lifson
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440

5.  Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.

Authors:  Sean C Patro; Livio Azzoni; Jocelin Joseph; Matthew G Fair; Juan G Sierra-Madero; Mohammed S Rassool; Ian Sanne; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2015-11-25       Impact factor: 4.962

6.  Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo.

Authors:  Andrea Gramatica; Roland Schwarzer; William Brantley; Benjamin Varco-Merth; Hannah S Sperber; Philip A Hull; Mauricio Montano; Stephen A Migueles; Danielle Rosenthal; Louise E Hogan; Jeffrey R Johnson; Thomas A Packard; Zachary W Grimmett; Eytan Herzig; Emilie Besnard; Michael Nekorchuk; Feng Hsiao; Steven G Deeks; Michael Snape; Bernard Kiernan; Nadia R Roan; Jeffrey D Lifson; Jacob D Estes; Louis J Picker; Eric Verdin; Nevan J Krogan; Timothy J Henrich; Mark Connors; Melanie Ott; Satish K Pillai; Afam A Okoye; Warner C Greene
Journal:  J Virol       Date:  2021-02-03       Impact factor: 6.549

7.  Comparison of predictors for terminal disease progression in simian immunodeficiency virus/simian-HIV-infected rhesus macaques.

Authors:  Naofumi Takahashi; Amir Ardeshir; Gerard E Holder; Yanhui Cai; Chie Sugimoto; Kazuyasu Mori; Mariluz Araínga; Ziyuan He; Yayoi Fukuyo; Woong-Ki Kim; Elizabeth S Didier; Marcelo J Kuroda
Journal:  AIDS       Date:  2021-06-01       Impact factor: 4.632

8.  PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.

Authors:  Meropi Aravantinou; Ines Frank; Magnus Hallor; Rachel Singer; Hugo Tharinger; Jessica Kenney; Agegnehu Gettie; Brooke Grasperge; James Blanchard; Andres Salazar; Michael Piatak; Jeffrey D Lifson; Melissa Robbiani; Nina Derby
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

9.  Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral- or bacterial-oriented immune responses.

Authors:  Pénélope Bourgoin; Géraldine Biéchelé; Inès Ait Belkacem; Pierre-Emmanuel Morange; Fabrice Malergue
Journal:  Immun Inflamm Dis       Date:  2020-02-07

10.  CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department.

Authors:  Pénélope Bourgoin; Thomas Soliveres; Alexandra Barbaresi; Anderson Loundou; Inès Ait Belkacem; Isabelle Arnoux; Denis Bernot; Marie Loosveld; Pierre-Emmanuel Morange; Pierre Michelet; Fabrice Malergue; Thibaut Markarian
Journal:  Cytometry A       Date:  2021-02-08       Impact factor: 4.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.